LIMINATUS PHARMA, INC. (LIMN) Operating cash flow 2024–2025
LIMINATUS PHARMA, INC. (LIMN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2024: -$1.5M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -586.6% |
| FY2024 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIMN financial trends
LIMN RevenueLIMN Net incomeLIMN Net marginLIMN Gross profitLIMN Gross marginLIMN Operating incomeLIMN Operating marginLIMN Free cash flowLIMN Capital expendituresLIMN Return on equityLIMN Stock buybacksLIMN Dividends paidLIMN Total assetsLIMN Total liabilitiesLIMN Shareholders’ equityLIMN overview →